Fig. 2

The prognostic significance of SPATS2L in AML. A OS of SPATS2L low (blue) group and the high (red) group from GEPIA database (log-rank tests; P-value = 0.0059)(http://gepia.cancer-pku.cn/). B OS of SPATS2L low (blue) group and the high (red) group from our cohort (log-rank tests; P-value = 0.009). C EFS of SPATS2L low (blue) group and the high (red) group from our cohort (log-rank tests; P-value < 0.0001). D RFS of SPATS2L low (blue) group and the high (red) group from our cohort (log-rank tests; P-value < 0.0001)